EE200000646A - Abakaviiri, lamivudiini ja zidovudiini sisaldavadhomogeensed farmatseutilised kompositsioonid - Google Patents
Abakaviiri, lamivudiini ja zidovudiini sisaldavadhomogeensed farmatseutilised kompositsioonidInfo
- Publication number
- EE200000646A EE200000646A EEP200000646A EEP200000646A EE200000646A EE 200000646 A EE200000646 A EE 200000646A EE P200000646 A EEP200000646 A EE P200000646A EE P200000646 A EEP200000646 A EE P200000646A EE 200000646 A EE200000646 A EE 200000646A
- Authority
- EE
- Estonia
- Prior art keywords
- lamivudine
- zidovudine
- pharmaceutical compositions
- compositions containing
- homogeneous pharmaceutical
- Prior art date
Links
- LHCOVOKZWQYODM-CPEOKENHSA-N 4-amino-1-[(2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;1-[(2r,4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1.O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 LHCOVOKZWQYODM-CPEOKENHSA-N 0.000 title 1
- 229960004748 abacavir Drugs 0.000 title 1
- MCGSCOLBFJQGHM-SCZZXKLOSA-N abacavir Chemical compound C=12N=CN([C@H]3C=C[C@@H](CO)C3)C2=NC(N)=NC=1NC1CC1 MCGSCOLBFJQGHM-SCZZXKLOSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809213.3A GB9809213D0 (en) | 1998-04-29 | 1998-04-29 | Pharmaceutical compositions |
| PCT/EP1999/002794 WO1999055372A1 (en) | 1998-04-29 | 1999-04-26 | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200000646A true EE200000646A (et) | 2002-04-15 |
Family
ID=10831228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200000646A EE200000646A (et) | 1998-04-29 | 1999-04-26 | Abakaviiri, lamivudiini ja zidovudiini sisaldavadhomogeensed farmatseutilised kompositsioonid |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1083932A1 (et) |
| JP (1) | JP2002512979A (et) |
| KR (1) | KR20010043128A (et) |
| CN (1) | CN1411380A (et) |
| AP (1) | AP2000001971A0 (et) |
| AU (1) | AU4135599A (et) |
| BR (1) | BR9910071A (et) |
| CA (1) | CA2330391A1 (et) |
| EA (1) | EA200000997A1 (et) |
| EE (1) | EE200000646A (et) |
| GB (1) | GB9809213D0 (et) |
| HR (1) | HRP20000732A2 (et) |
| HU (1) | HUP0101622A3 (et) |
| ID (1) | ID26955A (et) |
| IL (1) | IL139181A0 (et) |
| IS (1) | IS5675A (et) |
| NO (1) | NO20005418L (et) |
| NZ (1) | NZ507745A (et) |
| PL (1) | PL343710A1 (et) |
| SK (1) | SK16212000A3 (et) |
| TR (1) | TR200003157T2 (et) |
| WO (1) | WO1999055372A1 (et) |
| ZA (1) | ZA200005922B (et) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6875773B1 (en) | 1998-05-29 | 2005-04-05 | Ben M. Dunn | Combination therapy for treatment of FIV infection |
| CA2374198A1 (en) * | 1998-05-29 | 1999-12-02 | Maki Arai | Combination therapy for treatment of fiv infection |
| GB9820417D0 (en) * | 1998-09-18 | 1998-11-11 | Glaxo Group Ltd | Antiviral combinations |
| US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
| DE60219965T2 (de) * | 2002-04-23 | 2008-01-17 | Lupin Ltd., Mumbai | Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine |
| AR040242A1 (es) * | 2002-06-04 | 2005-03-23 | Glaxo Group Ltd | Composiciones farmaceuticas |
| CN100335125C (zh) * | 2003-06-03 | 2007-09-05 | 上海现代药物制剂工程研究中心 | 杀毒抗菌用长效干扰素喷鼻粉剂 |
| WO2006114709A1 (en) * | 2005-04-25 | 2006-11-02 | Aurobindo Pharma Limited | Pharmaceutical compositions of antiretrovirals |
| WO2007013047A2 (en) * | 2005-07-29 | 2007-02-01 | Ranbaxy Laboratories Limited | Water-dispersible anti-retroviral pharmaceutical compositions |
| ES2279707B1 (es) * | 2005-11-10 | 2008-06-01 | Combino Pharm, S.L. | Formulaciones orales que comprenden 3'-azidonucleosidos. |
| RU2010117269A (ru) * | 2007-10-02 | 2011-11-10 | Эмори Юнивёсити (Us) | Активные комбинации зидовудина и лекарств, которые являются селективными по отношению к мутации k65r в вич-полимеразе |
| WO2009092002A1 (en) * | 2008-01-17 | 2009-07-23 | Duquesne University Of The Holy Spirit | Antiretroviral drug formulations for treatment of children exposed to hiv/aids |
| BR112012018670A2 (pt) | 2010-01-27 | 2018-02-06 | Glaxosmithkline Llc | combinação, uso de um composto, composição farmacêutica, e, pacote de paciente |
| US20130115237A1 (en) | 2010-06-09 | 2013-05-09 | Vaccine Technologies, Incorporated | Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment |
| AU2013229274A1 (en) | 2012-03-05 | 2014-09-04 | Cipla Limited | Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine |
| NZ706223A (en) | 2012-10-23 | 2018-11-30 | Cipla Ltd | Pharmaceutical antiretroviral composition |
| PE20160194A1 (es) | 2013-06-13 | 2016-04-20 | Akebia Therapeutics Inc | Composiciones y metodos para tratar anemia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY115461A (en) * | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
| GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
-
1998
- 1998-04-29 GB GBGB9809213.3A patent/GB9809213D0/en not_active Ceased
-
1999
- 1999-04-26 AU AU41355/99A patent/AU4135599A/en not_active Abandoned
- 1999-04-26 BR BR9910071-1A patent/BR9910071A/pt not_active IP Right Cessation
- 1999-04-26 EA EA200000997A patent/EA200000997A1/ru unknown
- 1999-04-26 AP APAP/P/2000/001971A patent/AP2000001971A0/en unknown
- 1999-04-26 HR HR20000732A patent/HRP20000732A2/hr not_active Application Discontinuation
- 1999-04-26 IL IL13918199A patent/IL139181A0/xx unknown
- 1999-04-26 KR KR1020007012021A patent/KR20010043128A/ko not_active Withdrawn
- 1999-04-26 EE EEP200000646A patent/EE200000646A/et unknown
- 1999-04-26 PL PL99343710A patent/PL343710A1/xx unknown
- 1999-04-26 CN CN99807983A patent/CN1411380A/zh active Pending
- 1999-04-26 ID IDW20002479A patent/ID26955A/id unknown
- 1999-04-26 NZ NZ507745A patent/NZ507745A/en unknown
- 1999-04-26 HU HU0101622A patent/HUP0101622A3/hu unknown
- 1999-04-26 CA CA002330391A patent/CA2330391A1/en not_active Abandoned
- 1999-04-26 TR TR2000/03157T patent/TR200003157T2/xx unknown
- 1999-04-26 WO PCT/EP1999/002794 patent/WO1999055372A1/en not_active Ceased
- 1999-04-26 JP JP2000545569A patent/JP2002512979A/ja active Pending
- 1999-04-26 SK SK1621-2000A patent/SK16212000A3/sk unknown
- 1999-04-26 EP EP99924822A patent/EP1083932A1/en not_active Withdrawn
-
2000
- 2000-10-20 IS IS5675A patent/IS5675A/is unknown
- 2000-10-23 ZA ZA200005922A patent/ZA200005922B/xx unknown
- 2000-10-27 NO NO20005418A patent/NO20005418L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200005922B (en) | 2001-10-23 |
| AP2000001971A0 (en) | 2000-12-31 |
| EP1083932A1 (en) | 2001-03-21 |
| JP2002512979A (ja) | 2002-05-08 |
| AU4135599A (en) | 1999-11-16 |
| NZ507745A (en) | 2004-07-30 |
| HUP0101622A3 (en) | 2003-09-29 |
| KR20010043128A (ko) | 2001-05-25 |
| TR200003157T2 (tr) | 2001-01-22 |
| CA2330391A1 (en) | 1999-11-04 |
| HUP0101622A2 (hu) | 2002-03-28 |
| BR9910071A (pt) | 2000-12-26 |
| WO1999055372A1 (en) | 1999-11-04 |
| IS5675A (is) | 2000-10-20 |
| SK16212000A3 (sk) | 2001-07-10 |
| NO20005418D0 (no) | 2000-10-27 |
| NO20005418L (no) | 2000-11-29 |
| IL139181A0 (en) | 2001-11-25 |
| HRP20000732A2 (en) | 2001-02-28 |
| ID26955A (id) | 2001-02-22 |
| EA200000997A1 (ru) | 2001-06-25 |
| GB9809213D0 (en) | 1998-07-01 |
| PL343710A1 (en) | 2001-08-27 |
| CN1411380A (zh) | 2003-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69924999D1 (de) | Lipasehemmer enthaltende pharmazeutische zusammensetzungen | |
| NO20002359L (no) | Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene | |
| EE200000646A (et) | Abakaviiri, lamivudiini ja zidovudiini sisaldavadhomogeensed farmatseutilised kompositsioonid | |
| ID26982A (id) | Komposisi farmasi topiramat | |
| BR9913138B1 (pt) | Derivado de quinolin-2-ona substituído com alquinila e composição farcêutica contendo o mesmo | |
| EE200000468A (et) | Ühendid, nende kasutamine ja farmatseutiline kompositsioon | |
| ID22981A (id) | Komposisi pengelantang | |
| DE69726015D1 (de) | Pharmazeutische zusammensetzung enthaltend koenzym q-10 | |
| ID22891A (id) | Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan | |
| ID21491A (id) | Komposisi aerosol farmasi | |
| ATE228357T1 (de) | Nukleotid-analoge zusammensetzung | |
| NO995925D0 (no) | Farmasöytiske sammensetninger omfattende cyklodekstriner | |
| DK1139739T3 (da) | Agrokemiske præparater | |
| NO20006520D0 (no) | Adenosinderivater | |
| DK1112266T3 (da) | Substituerede 4-amino-2-arylpyrimidiner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem | |
| DE69900561D1 (de) | Pharmazeutische Zusammensetzungen enthaltend Mupirocin | |
| ID17774A (id) | Komposisi farmasi antitrombosis | |
| DE59801987D1 (de) | Pharmazeutische zusammensetzung enthaltend peptichemio | |
| EE03806B1 (et) | Lamivudiini ja sidovudiini sisaldavad farmatseutilised kompositsioonid | |
| ID29294A (id) | Komposisi farmasi | |
| IT1298731B1 (it) | Composizioni farmaceutiche contenenti complessi di inclusione con melatonina | |
| EP1124557A4 (en) | Pharmaceutical composition | |
| ID23531A (id) | Komposisi farmasi | |
| HK1034188A (en) | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine | |
| BR1100755A (pt) | composição farmacêutica |